Skip to content
Home/Companies/Healthcare/Radioterapia de Protones

Radioterapia de Protones

Healthcare·Spain·Exited 2024·Held 7yr
Entry
2017
Hold
7yr
Exit
2024

Who owns Radioterapia de Protones?

Radioterapia de Protones was owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage) from 2017 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-09

Columbus Venture Partners
Investor
Columbus Venture Partners
Columbus Life Science Fund II · 2019 · Life Sciences VC

Key facts

HQSpain
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from Columbus Life Science Fund II

Other portfolio companies in the same fund.

Minoryx Therapeutics
Minoryx Therapeutics
Active
BiotechSpain· 2022
NeRRe Therapeutics
Active
BiotechUnited Kingdom· 2021
Highlight Therapeutics
Highlight Therapeutics
Active
BiotechSpain· 2020
RECOVID Solutions
Exited 2022
HealthTechSpain· 2020
to
Sanifit Therapeutics
Exited 2021
BiotechSpain· 2019
to
Viralgen Commercial
Viralgen Commercial
Exited 2021
BiotechSpain· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Radioterapia de Protones

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Radioterapia de Protones.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue